Hydreight Announces Exciting New Development: Normal Course Issuer Bid!
LAS VEGAS and VANCOUVER, British Columbia, Sept. 30, 2024 (GLOBE NEWSWIRE) —
Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) (FSE:SO6), a fast-growing mobile clinical network and medical platform, has announced its intention to make a normal course issuer bid (the “Bid”). This bid will see the company purchasing for cancellation, from time to time, up to 1,378,633 of its issued and outstanding common shares. This represents approximately 3.42% of the company’s currently outstanding common shares and approximately 10.0% of the company’s Public Float.
The Bid Details:
The Bid will begin on October 4, 2024, and is set to terminate on October 3, 2025. However, it may end earlier if the Bid is completed or at the option of the Company. Research Capital Corporation of Vancouver, British Columbia will be conducting the Bid on behalf of Hydreight Technologies Inc.
This announcement marks a significant development for the company and its shareholders. By repurchasing its own shares, Hydreight aims to increase shareholder value and send a positive signal about the company’s financial health and future prospects. This move also indicates the company’s confidence in its long-term growth potential.
Hydreight Technologies Inc. has been at the forefront of delivering flexible at-home medical services across 50 states in the United States. With this new development, the company is reinforcing its commitment to innovation and excellence in the healthcare industry.
Overall, the Normal Course Issuer Bid is a strategic move that reflects Hydreight’s proactive approach to enhancing shareholder value and strengthening its position in the market.
How this will affect you:
As a shareholder of Hydreight Technologies Inc., this announcement could have a direct impact on your investment. The repurchase of shares through the Bid may lead to an increase in the company’s stock price, potentially boosting the value of your investment. It also indicates the company’s confidence in its performance and long-term growth prospects, which could instill further confidence in investors.
How this will affect the world:
Hydreight’s Normal Course Issuer Bid showcases the company’s commitment to driving innovation in the healthcare industry. By focusing on providing flexible at-home medical services, Hydreight is contributing to the advancement of healthcare accessibility and convenience. This development may inspire other companies to explore similar initiatives, ultimately leading to a positive transformation in the way healthcare services are delivered globally.
Conclusion:
In conclusion, Hydreight Technologies Inc.’s announcement of a Normal Course Issuer Bid represents a significant milestone for the company and its stakeholders. By repurchasing its own shares, Hydreight is demonstrating its commitment to enhancing shareholder value and reinforcing its position as a leading provider of at-home medical services. This strategic move not only benefits shareholders but also signals the company’s confidence in its future growth trajectory. Overall, the Bid underscores Hydreight’s dedication to innovation and excellence in the healthcare sector, setting a positive example for the industry as a whole.
